Related Experiment Video
Updated: Sep 26, 2026

A Video Protocol of a Randomized Controlled Clinical Trial - Electrochemotherapy of Cutaneous Metastases with Reduced Dose Bleomycin (BLESS Trial)
Published on: June 9, 2026
Large-dose intravenous methotrexate-induced cutaneous toxicity: can oral magnesium oxide reduce pain?
Santhanam Suresh1, Sara Lozono, Steven C Hall
1Department of *Pediatric Anesthesiology, Children's Memorial Hospital, and †Department of Anesthesiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; and ‡Division of Anesthesiology, The Cleveland Clinic Foundation, Cleveland, Ohio.
Implications:
Chemotherapy for cancer is associated with pain including cutaneous vasculitis. Magnesium, an N-methyl-D-aspartic acid-receptor antagonist, was used successfully to treat an adolescent with pain caused by cutaneous vasculitis secondary to methotrexate therapy.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Therapeutic Drug Monitoring: Affecting Factors